Insert graphic here:
width: 175px
height: 64px
 |
|||||
 |
 |
 |
 |
 |
 |
|
PFIZER VICE PRESIDENT ELECTED TO CBIA BOARD OF DIRECTORS
Bormann is vice president in Pfizer Global Research and Development and the world-wide head of strategic alliances at Pfizer Inc, based in New London. She is one of 13 new members elected to the CBIA board who will begin their terms Dec. 1. CBIA is the state’s largest business organization, with 10,000 member companies throughout Connecticut. The board of directors approves the organization’s plans, policies and strategies, and particularly focuses on ways to make Connecticut a better place to do business and create jobs. Bormann joined Pfizer in 1996 as a project analyst in the R&D operations group, presently called strategic alliances. Since joining Pfizer, she has worked in a number of positions of increasing responsibility, most recently serving as global portfolio executive director for early development technologies. Prior to joining Pfizer, Bormann was a principal scientist at Boehringer Ingelheim Pharmaceuticals Inc., in Ridgefield, working in drug discovery in the area of molecular biology of cell adhesion and T-cell based therapeutic approaches. She also worked as a research affiliate at Yale University, in the Department of Pathology. Bormann is a graduate of Fairfield University and earned her Ph.D. in biomedical science from the University of Connecticut Health Center in Farmington. She lives in Old Lyme with her husband and two daughters. ###
|
 |
© Copyright 2003 Connecticut Business & Industry Association, cbia.com. All rights reserved. |
 |
The Connecticut Business & Industry Association (CBIA) elected Dr. B.J. Bormann to a four-year term on its board of directors at its Oct. 26 Annual Meeting.